HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 39 filers reported holding HEPION PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $102,544 | +158.6% | 132,059 | 0.0% | 0.00% | – |
| Q4 2022 | $39,657 | -40.8% | 132,059 | 0.0% | 0.00% | – |
| Q3 2022 | $67,000 | -13.0% | 132,059 | -0.9% | 0.00% | – |
| Q2 2022 | $77,000 | -58.2% | 133,264 | -6.3% | 0.00% | – |
| Q1 2022 | $184,000 | +14.3% | 142,204 | +0.9% | 0.00% | – |
| Q4 2021 | $161,000 | -26.8% | 140,999 | -1.7% | 0.00% | – |
| Q3 2021 | $220,000 | -23.6% | 143,428 | -1.4% | 0.00% | – |
| Q2 2021 | $288,000 | +7.5% | 145,515 | 0.0% | 0.00% | – |
| Q1 2021 | $268,000 | +92.8% | 145,515 | +129.5% | 0.00% | – |
| Q4 2020 | $139,000 | – | 63,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PVG ASSET MANAGEMENT CORP | 189,616 | $375,439,000 | 1.17% |
| Ikarian Capital, LLC | 1,365,059 | $2,703,000 | 0.22% |
| Altium Capital Management LP | 446,000 | $883,000 | 0.20% |
| ASSET MANAGEMENT CORP /IL/ /ADV | 91,500 | $181,000 | 0.10% |
| Virtu Financial LLC | 113,869 | $225,000 | 0.02% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 10,000 | $20,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 155,069 | $307,000 | 0.01% |
| McAdam, LLC | 55,978 | $86,000 | 0.01% |
| Moloney Securities Asset Management, LLC | 27,340 | $54,000 | 0.01% |
| Allen Capital Group, LLC | 23,685 | $47,000 | 0.01% |